Cme (CME) EV to EBITDA (2009 - 2026)

Cme (CME) has reported EV to EBITDA for 18 consecutive years, with 67.88 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 19.09% year-over-year to 67.88 in Q2 2026; TTM through Jun 2026 was 17.16, a 24.1% decrease from a year earlier, with the FY2025 full-year figure at 22.1, up 7.94% from the prior year.
• EV to EBITDA was 67.88 for Q2 2026 at Cme, down from 78.05 in the prior quarter.
• Over five years, EV to EBITDA peaked at 94.75 in Q3 2025 and troughed at 66.78 in Q2 2024.
• A 5-year average of 81.17 and a median of 82.18 in 2023 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA plunged 31.13% in 2022 and grew 29.67% in 2025, its largest moves.
• Over 5 years, EV to EBITDA stood at 86.1 in 2022, then declined by 2.28% to 84.14 in 2023, then increased by 1.02% to 85.0 in 2024, then climbed by 7.86% to 91.68 in 2025, then slipped by 25.96% to 67.88 in 2026.
• The last three EV to EBITDA figures came in at 67.88 (Q2 2026), 78.05 (Q1 2026), and 91.68 (Q4 2025), per Business Quant data.